SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 12/28/11 Weikang Bio-Tech Group Co., Inc. 10-K/A 12/31/10 5:141K Vintage/FA |
Document/Exhibit Description Pages Size 1: 10-K/A Amendment to Annual Report HTML 64K 2: EX-31.1 Certification per Sarbanes-Oxley Act (Section 302) HTML 15K 3: EX-31.2 Certification per Sarbanes-Oxley Act (Section 302) HTML 15K 4: EX-32.1 Certification per Sarbanes-Oxley Act (Section 906) HTML 11K 5: EX-32.2 Certification per Sarbanes-Oxley Act (Section 906) HTML 11K
Unassociated Document |
Nevada
|
26-2816569
|
|
(State or other jurisdiction of
|
(I.R.S. employer
|
|
incorporation or organization)
|
identification number)
|
Title of each class
|
Name of each exchange on which registered
|
|
None
|
Not Applicable
|
Large accelerated filer ¨
|
Accelerated filer ¨
|
Non-accelerated filer ¨
|
Smaller reporting company x
|
·
|
a need for additional controls and procedures to improve the recordkeeping systems at the Company; and
|
·
|
a need for additional financial personnel, particularly at the executive level, with experience with U.S. public companies and an appropriate level of knowledge, experience and training in the application of generally accepted accounting principles in the United States.
|
Exhibit No.
|
Description
|
|
2.1
|
Share Exchange Agreement among Expedition Leasing Inc. (“Expedition Leasing”), certain stockholders of Expedition Leasing, Sinary Bio-Technology Holding Group, Inc. (“Sinary”) and the sole stockholder of Sinary dated December 7, 2007 (1)
|
|
2.2
|
Equity Transfer Agreement between Sinary and the owners of 100% of the registered equity of Heilongjiang Weikang Bio-Technology Group Co., Ltd. Dated October 25, 2007 (1)
|
|
2.3
|
Agreement and Plan of Merger dated as of June 4, 2008 between Expedition Leasing and Weikang (2)
|
|
3.1
|
Articles of Incorporation of Weikang (2)
|
|
3.2
|
Bylaws of Weikang (2)
|
|
4.1
|
Form of Series A and B Common Stock Warrant (3)
|
|
4.2
|
Form of Series C Warrant (5)
|
|
4.3
|
Form of Series D Warrant (5)
|
|
4.4
|
Form of warrants issued to the placement agents (5)
|
|
4.5
|
Form of Subscription Agreement, by and between Weikang Bio-Technology Group Company, Inc. and the investors. (5)
|
|
4.6
|
Form of Registration Rights Agreement, by and between Weikang Bio-Technology Group Company, Inc. and the investors. (5)
|
|
4.7
|
Form of Lock-Up Agreement (5)
|
|
10.1
|
Stock Transfer Agreement dated as of June 30, 2008 by and among Heilongjiang Weikang Bio-Technology Group Co., Ltd., Beijing Shiji Qisheng Trading Co., Ltd., Tri-H Trade (U.S.A.) Co., Ltd., and Tianfang (Guizhou) Pharmaceutical Co., Ltd. (4)
|
|
10.2
|
The Weikang Bio-Technology Group Company, Inc. 2008 Stock Incentive Plan (2)
|
|
10.3
|
Subscription Agreement dated January 20, 2010, between Weikang and the subscribers identified on the signature pages thereto (3)
|
|
10.4
|
Investor Relations Escrow Agreement dated January 20, 2010, among Weikang, the escrow agent named therein and Opus Holdings Three, Ltd. (3)
|
|
10.5
|
Lease Agreement dated January 1, 2008 between Heilongjiang Weikang Bio-Technology Group and Harbin Dongfeng Pharmaceutical Corp. Ltd. relating to the lease of the workshop and technology for manufacturing royal jelly.(6)
|
|
10.6
|
Shell Company Purchase Agreement dated December 8, 2007 between the Company and Yin Wang relating the advance from an officer of the Company(6)
|
|
10.7
|
English translation of land use right certificate issued by Xiuwen County Land Bureau and Bureau of Real Estate Management of Guiyang City for the benefit of Tianfang (Guizhou) Pharmaceutical Co., Ltd., which expires December 9, 2051(6)
|
|
10.8
|
English translation of land use right certificate issued by Bureau of Land and Resources of Shuang-Cheng City for the benefit of Heilongjiang Weikang Bio-Technology Group, which expires April 8, 2055(6)
|
|
10.9
|
Make Good Securities Escrow Agreement, dated December 2, 2010, by and between Weikang Bio-Technology Group Company, Inc., Sichenzia Ross Friedman Ference LLP, as escrow agent, and Lucky Wheel Limited.(5)
|
|
10.10
|
Investor and Public Relations Escrow Agreement, dated December 2, 2010, by and between Weikang Bio-Technology Group Company, Inc., Sichenzia Ross Friedman Ference LLP, as escrow agent, and MidSouth Investor Fund LP, as representative for the investors.(5)
|
|
10.11
|
Escrow Deposit Agreement, dated October 25, 2010 and amendment thereto dated November 24, 2010, by and between Weikang Bio-Technology Group Company, Inc., Hunter Wise Securities, LLC, and Signature Bank, as escrow agent. (5)
|
|
21.1
|
List of Subsidiaries (6)
|
|
23.1
|
Consent of Independent Registered Public Accounting Firm (7)
|
|
31.1
|
Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
|
31.2
|
Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
|
|
32.1
|
Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
|
|
32.2
|
Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
|
WEIKANG BIO-TECHNOLOGY GROUP COMPANY, INC.
|
|
Date: December 28, 2011
|
/s/ Yin Wang
|
Chief Executive Officer
|
Signature
|
Title
|
Date
|
||
/s/ Yin Wang
|
Chief Executive Officer and Chairman of the Board
|
|||
/s/ Baolin Sun
|
Chief Financial Officer
|
|||
/s/ Jeffrey Chuang
|
Director
|
|||
/s/ Allen Zhang
|
Director
|
|||
/s/ Yan Huang
|
Director
|
|||
This ‘10-K/A’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 12/28/11 | 10-Q/A | ||
3/22/11 | 10-K, 8-K | |||
3/18/11 | ||||
For Period End: | 12/31/10 | 10-K | ||
12/8/10 | 8-K | |||
12/2/10 | 8-K | |||
11/24/10 | 8-K | |||
10/25/10 | ||||
6/30/10 | 10-Q, 4 | |||
3/25/10 | S-1 | |||
1/26/10 | ||||
1/20/10 | ||||
7/24/08 | ||||
6/30/08 | ||||
6/4/08 | ||||
5/14/08 | ||||
1/1/08 | ||||
12/10/07 | ||||
12/8/07 | ||||
12/7/07 | ||||
10/25/07 | ||||
List all Filings |